VRSN vs. BSX
VRSN (VeriSign, Inc.) and BSX (Boston Scientific Corporation) are both stocks. VRSN operates in Software - Infrastructure (Technology), while BSX operates in Medical Devices (Healthcare). Over the past 10 years, VRSN returned 12.83%/yr vs 7.42%/yr for BSX. At a 0.27 correlation, their price movements are largely independent.
Performance
VRSN vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VRSN achieves a 15.94% return, which is significantly higher than BSX's -50.80% return. Over the past 10 years, VRSN has outperformed BSX with an annualized return of 12.83%, while BSX has yielded a comparatively lower 7.42% annualized return.
VRSN
- 1D
- 0.11%
- 1M
- -4.91%
- YTD
- 15.94%
- 6M
- 16.40%
- 1Y
- 0.55%
- 3Y*
- 8.34%
- 5Y*
- 5.15%
- 10Y*
- 12.83%
BSX
- 1D
- -0.55%
- 1M
- -11.59%
- YTD
- -50.80%
- 6M
- -49.33%
- 1Y
- -52.40%
- 3Y*
- -2.85%
- 5Y*
- 1.80%
- 10Y*
- 7.42%
VRSN vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VRSN VeriSign, Inc. | 15.94% | 18.41% | 0.49% | 0.25% | -19.06% | 17.29% | 12.31% | 29.93% | 29.58% | 50.44% |
BSX Boston Scientific Corporation | -50.80% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Correlation
The correlation between VRSN and BSX is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.33 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.38 |
Correlation (All Time) Calculated using the full available price history since Jan 30, 1998 | 0.27 |
The correlation between VRSN and BSX shifts across timeframes, from 0.16 (1 year) to 0.38 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
VRSN:
$25.69B
BSX:
$70.13B
VRSN:
$9.04
BSX:
$2.38
VRSN:
30.95
BSX:
19.74
VRSN:
4.54
BSX:
0.44
VRSN:
15.46
BSX:
3.40
VRSN:
$1.68B
BSX:
$20.62B
VRSN:
$1.49B
BSX:
$14.52B
VRSN:
$1.18B
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VRSN vs. BSX — Risk / Return Rank
VRSN
BSX
VRSN vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VeriSign, Inc. (VRSN) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VRSN | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.53 | ||
| Sortino ratioReturn per unit of downside risk | +2.49 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 0.67 | +0.36 |
| Calmar ratioReturn relative to maximum drawdown | 0.02 | -0.93 | +0.95 |
| Martin ratioReturn relative to average drawdown | 0.04 | -2.00 | +2.04 |
Loading charts...
Drawdowns
VRSN vs. BSX - Drawdown Comparison
The maximum VRSN drawdown since its inception was -98.37%, which is greater than BSX's maximum drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for VRSN and BSX.
Loading charts...
Drawdown Indicators
| VRSN | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.37% | -89.15% | -9.22% |
Max Drawdown (1Y)Largest decline over 1 year | -30.21% | -56.62% | +26.41% |
Max Drawdown (3Y)Largest decline over 3 years | -30.21% | -56.62% | +26.41% |
Max Drawdown (5Y)Largest decline over 5 years | -38.85% | -56.62% | +17.77% |
Max Drawdown (10Y)Largest decline over 10 years | -38.85% | -56.62% | +17.77% |
Current DrawdownCurrent decline from peak | -9.71% | -56.62% | +46.91% |
Average DrawdownAverage peak-to-trough decline | -56.97% | -38.76% | -18.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.19% | 26.23% | -11.04% |
Volatility
VRSN vs. BSX - Volatility Comparison
The current volatility for VeriSign, Inc. (VRSN) is 9.36%, while Boston Scientific Corporation (BSX) has a volatility of 15.84%. This indicates that VRSN experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VRSN | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.36% | 15.84% | -6.48% |
Volatility (6M)Calculated over the trailing 6-month period | 20.91% | 32.83% | -11.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.93% | 34.77% | -6.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.14% | 25.69% | -0.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.25% | 27.29% | -1.04% |
Dividends
VRSN vs. BSX - Dividend Comparison
VRSN's dividend yield for the trailing twelve months is around 1.13%, while BSX has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% |
VRSN VeriSign, Inc. | 1.13% | 0.95% |
Financials
VRSN vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between VeriSign, Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VRSN vs. BSX - Profitability Comparison
VRSN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, VeriSign, Inc. reported a gross profit of 379.70M and revenue of 428.90M. Therefore, the gross margin over that period was 88.5%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
VRSN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, VeriSign, Inc. reported an operating income of 293.60M and revenue of 428.90M, resulting in an operating margin of 68.5%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
VRSN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, VeriSign, Inc. reported a net income of 214.50M and revenue of 428.90M, resulting in a net margin of 50.0%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
VRSN and BSX have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BSX has higher volatility (15.84%) compared to VRSN (9.36%). In terms of maximum drawdown, VRSN dropped -98.37% vs BSX's -89.15%.
VRSN currently has the higher Sharpe Ratio (0.02 vs -1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VRSN and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer